Bogart Wealth »

Lipocine shares owned by Bogart Wealth

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Bogart Wealth from 13F filings

Historical chart of Bogart Wealth investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Bogart Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Bogart Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $24 3 8.00

More positions owned by Bogart Wealth

Exxon Mobil Corp Stock (XOM)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Msci Acwi Etf Etf (ACWI)
Vanguard Total Bond Market Etf Etf (BND)
Capital Group Dividend Value Etf Etf (CGDV)
Victoryshares Core Intermediate Bond Etf Etf (UITB)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Columbia Research Enhanced Core Etf Etf (RECS)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Schwab Fundamental Emerging Markets Equity Etf Etf (FNDE)
Invesco Nasdaq 100 Etf Etf (QQQM)
Invesco S&p 500 Top 50 Etf Etf (XLG)
Vanguard Total International Stock Etf Etf (VXUS)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Global X Adaptive U.s. Factor Etf Etf (AUSF)

View all positions for Bogart Wealth

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Diadema Partners
Vanguard Group
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Renaissance Technologies
Two Sigma Investments

View all funds holding Lipocine